AustraliaÚltimas notícias

Sims (ASX:SGM) announced an upward revision to its expected financial performance for the 2026 fiscal year.

Stealth Global (ASX:SGI) forecast record annual sales of at least $165 million for the 2026 financial year.

Symal Group (ASX:SYL) agreed to acquire 100% of Shamrock Civil for an upfront payment of $51 million.

Growthpoint Properties Australia (ASX:GOZ) secured 54,721sqm in office leasing transactions and agrees terms for 27,602sqm more in FY26.

Flight Centre Travel Group (ASX:FLT) has lowered its 2026 underlying profit guidance to $275–$295 million due to Middle East conflict disruptions.

The Albanese government committed $3.6 billion to extend its childcare wage subsidy for two years to secure a 15% pay rise for early educators.

Kalshi co-founder Tarek Mansour discusses the increased utilization of hedging at the Bloomberg Market Structure Conference.

Hancock Iron Ore has cut jobs at its Pilbara operations while maintaining system production above 63 million tonnes annually.

ARN Media (ASX:A1N) has entered a binding settlement to resolve all outstanding Federal Court proceedings with Kyle Sandilands.

The Australian Prudential Regulation Authority has finalised a maximum 12-year term limit for board directors to boost governance.

US Senator Elizabeth Warren, a Massachusetts Democrat, says President Donald Trump "can't point to where we're better off" after the war in Iran. Speaking on "Balance of Power: Evening Edition," Senator Warren also discusses Defense Secretary Pete Hegseth's military budget request, her criticisms of Kevin Warsh as chair of the Federal Reserve, the state of housing and the SpaceX IPO.

David Roman, US medtech and healthcare IT research analyst for Goldman Sachs, said that AI play a 'significant' role in helping patients stay on top of their diabetes, with companies like Abbott and Dexcom using new technology to count carbohydrates and deliver the right amount of insulin. Roman, joined by Bloomberg health reporter Madison Muller, said that he came away from Goldman Sach's annual medtech conference 'very bullish' on innovation across the industry.